Roberto Díaz Beveridge

Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2

Teresa Macarulla, Roberto Pazo-Cid, Carmen Guillén‐Ponce et al. · Journal of Clinical Oncology · 2018 · 94 citations

Medicine, Oncology, Pharmacology +17

Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial

María González‐Cao, Clara Mayo de las Casas, Juana Oramás et al. · Nature Communications · 2021 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17

Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial

Mrinal M. Gounder, Albiruni Abdul Razak, Neeta Somaiah et al. · Journal of Clinical Oncology · 2022 · 42 citations · Full text

Medicine, Oncology, Pharmacology +14

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

Jitendra PS. Sawhney, V A Kothiwale, Vikas Bisne et al. · Indian Heart Journal · 2018 · 21 citations · Full text

Medicine, Cardiology, Internal Medicine +10

Epidemiological pattern and time trends in testicular germ-cell tumors: a single institution 20-year experience

J. Molina Saera, Jorge Aparicio Urtasún, Roberto Díaz Beveridge et al. · Clinical & Translational Oncology · 2006 · 13 citations

Medicine, Oncology, Pathology +14